<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Royal (Dick) School of Veterinary Scienc</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1C2EEA30-8EDC-4335-B896-240E712D2D9C"><gtr:id>1C2EEA30-8EDC-4335-B896-240E712D2D9C</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:otherNames>Andrew</gtr:otherNames><gtr:surname>Mabbott</gtr:surname><gtr:orcidId>0000-0001-7395-1796</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FD00831X%2F3"><gtr:id>A20B2CD3-EF9C-4046-ACF8-2D08CDE8ACE4</gtr:id><gtr:title>Investigating the role of follicular dendritic cells in TSE agent neuroinvasion from lymphoid tissues</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/D00831X/3</gtr:grantReference><gtr:abstractText>Transmissible spongiform encephalophathies (TSEs) are fatal neurodegenerative diseases. Examples include Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform encephalopathy (BSE), chronic wasting disease (CWD) in mule deer and elk, and scrapie in sheep and goats. Most natural transmissions of TSE agents occur by peripheral exposure, eg: ingestion (oral). After inoculation, TSE agents usually accumulate upon follicular dendritic cells (FDCs) in lymphoid tissues before they infect the central nervous system (CNS). FDCs are critical for the spread of disease to the CNS (neuroinvasion) as in their absence agent accumulation in lymphoid tissues and neuroinvasion are impaired. The nature of the TSE agent is not known, but an abnormal isoform (PrPSc) of the host cellular prion protein (PrPc), co-purifies with infectivity. Indeed, PrPSc is detected upon FDCs after inoculation with some TSE agents. Cells must express cellular PrPc to replicate TSE agents. Although PrPc is detected on FDCs in uninfected mice, it is not known if FDCs express PrPc and replicate TSE agents. Treatments that deplete FDCs reduce susceptibility to TSE agents. Thus, a thorough understanding of the involvement of FDCs in TSE pathogenesis is important when determining risk, and designing therapeutic strategies against peripherally-acquired TSEs. FDCs trap and retain native antigens on their surfaces for long durations. Thus their involvement in TSE pathogenesis may be to trap TSE agents released from infected cells and mediate their transfer to neurones. Many cell types secrete exosomes enriched in cell-specific protein. FDCs can bind exosomes, and as a consequence display proteins on their surfaces that they do not express at the mRNA level. PrPc and PrPSc can be released in exosomes, providing a mechanism by which FDCs might acquire PrPc and TSE agents from other infected cells. Experiments have excluded bone marrow-derived cells as major providers of the PrPc and PrPSc detected on FDCs. However, the involvement of non-haematopoietic cells (eg: muscle, endothelial, epithelial or nerve cells) cannot be excluded. We will use novel approaches to provide important information on FDC biology and their involvement in TSE pathogenesis. In particular we will address the following objectives: O-1: Do FDCs express PrPc or acquire it from other host cells? O-2: Do FDCs replicate TSE agents, or acquire them from other infected host cells? Increased understanding of the FDCs involvement in TSE pathogenesis may aid the development of therapeutic strategies.</gtr:abstractText><gtr:technicalSummary>Transmissible spongiform encephalophathies (TSEs) are fatal neurodegenerative diseases. Examples include Creutzfeldt- Jakob disease (CJD) in humans, bovine spongiform encephalopathy (BSE), chronic wasting disease (CWD) in mule deer and elk, and scrapie in sheep and goats. Most natural transmissions of TSE agents occur by peripheral exposure, eg: ingestion (oral). After inoculation, TSE agents usually accumulate upon follicular dendritic cells (FDCs) in lymphoid tissues before they infect the central nervous system (CNS). FDCs are critical for the spread of disease to the CNS (neuroinvasion) as in their absence agent accumulation in lymphoid tissues and neuroinvasion are impaired. The nature of the TSE agent is not known, but an abnormal isoform (PrPSc) of the host cellular prion protein (PrPc), co-purifies with infectivity. Indeed, PrPSc is detected upon FDCs after inoculation with some TSE agents. Cells must express cellular PrPc to replicate TSE agents. Although PrPc is detected on FDCs in uninfected mice, it is not known if FDCs express PrPc and replicate TSE agents. Treatments that deplete FDCs reduce susceptibility to TSE agents. Thus, a thorough understanding of the involvement of FDCs in TSE pathogenesis is important when determining risk, and designing therapeutic strategies against peripherally- acquired TSEs. FDCs trap and retain native antigens on their surfaces for long durations. Thus their involvement in TSE pathogenesis may be to trap TSE agents released from infected cells and mediate their transfer to neurones. Many cell types secrete exosomes enriched in cell-specific protein. FDCs can bind exosomes, and as a consequence display proteins on their surfaces that they do not express at the mRNA level. PrPc and PrPSc can be released in exosomes, providing a mechanism by which FDCs might acquire PrPc and TSE agents from other infected cells. Experiments have excluded bone marrow-derived cells as major providers of the PrPc and PrPSc detected on FDCs. However, the involvement of non-haematopoietic cells (eg: muscle, endothelial, epithelial or nerve cells) cannot be excluded. We will use novel approaches to provide important information on FDC biology and their involvement in TSE pathogenesis. In particular we will address the following objectives: O-1: Do FDCs express PrPc or acquire it from other host cells? O-2: Do FDCs replicate TSE agents, or acquire them from other infected host cells? Increased understanding of the FDCs involvement in TSE pathogenesis may aid the development of therapeutic strategies.</gtr:technicalSummary><gtr:fund><gtr:end>2010-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>162385</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Keeping bugs at Bay: a Public Engagement Activity at the Royal Highland Show 2015</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>43019B20-C864-4A58-8E24-612B82C631C4</gtr:id><gtr:impact>This activity aims to teach people how the immune system fights bugs.</gtr:impact><gtr:outcomeId>5899dd4cb80251.53968157</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Protein sheds insight into spread of vCJD to the brain</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>38A98DBC-C85C-4F0D-BF8A-61AE06D07A89</gtr:id><gtr:impact>Press release describing our study published in PLoS Pathogens: http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1002402</gtr:impact><gtr:outcomeId>5899e1936720b6.06271122</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/uk-scotland-edinburgh-east-fife-15988283</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Keeping bugs at Bay: a Public Engagement Activity at the Roslin Institute 2014</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6ADD6D7D-A4EA-4626-93B5-4D85EC767662</gtr:id><gtr:impact>This activity aims to teach people how the immune system fights bugs.</gtr:impact><gtr:outcomeId>5899dcbbea4019.28522430</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Our data showing that the effects of aging on follicular dendritic cells dramatically reduce susceptibility to peripherally-acquired prion infections were discussed at the November 2009 meeting of the UK Spongiform Encephalopathies Advisory Committee (for minutes see http://www.seac.gov.uk/papers/103-2.pdf) and received significant media interest (eg: BBC website http://news.bbc.co.uk/1/hi/scotland/edinburgh_and_east/8307551.stm).</gtr:description><gtr:firstYearOfImpact>2009</gtr:firstYearOfImpact><gtr:id>3BB36FFB-3AC6-4CA8-876F-7EB01A7BCF9A</gtr:id><gtr:impactTypes><gtr:impactType>Policy &amp; public services</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56cc58d7128558.25614488</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Prion diseases are characterised by the accumulation of PrPSc, an abnormally folded isoform of the cellular prion protein (PrPC), in affected tissues. Following peripheral exposure high levels of prion-specific PrPSc accumulate first upon follicular dendritic cells (FDC) in lymphoid tissues before spreading to the CNS. Expression of PrPC is mandatory for cells to sustain prion infection and FDC appear to express high levels. However, whether FDC actively accumulate prions or simply acquire them from other infected cells is uncertain. In the attempts to-date to establish the role of FDC in prion pathogenesis it was not possible to dissociate the Prnp expression of FDC from that of the nervous system and all other non-haematopoietic lineages. This is important as FDC may simply acquire prions after synthesis by other infected cells. To establish the role of FDC in prion pathogenesis transgenic mice were created in which PrPC expression was specifically &amp;quot;switched on&amp;quot; or &amp;quot;off&amp;quot; only on FDC. We have shown that PrPC-expression only on FDC is sufficient to sustain prion accumulation in the spleen. Furthermore, prion accumulation is blocked in the spleen when PrPC-expression is specifically ablated only on FDC. These data definitively demonstrate that FDC are the essential sites of prion accumulation in lymphoid tissues. The demonstration that Prnp-ablation only on FDC blocked splenic prion accumulation without apparent consequences for FDC status represents a novel opportunity to prevent neuroinvasion by modulation of PrPC expression on FDC.</gtr:description><gtr:exploitationPathways>The demonstration that Prnp-ablation only on FDC blocked splenic prion accumulation without apparent consequences for FDC status represents a novel opportunity to prevent neuroinvasion by modulation of PrPC expression on FDC. These data will aid the development of treatments to reduce susceptibility to prion infections and block the spread of prion disease.</gtr:exploitationPathways><gtr:id>65F09762-0B7F-48AC-81AC-0F2684C524F2</gtr:id><gtr:outcomeId>56cc3e9e557963.50903651</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare</gtr:sector></gtr:sectors><gtr:url>http://dx.plos.org/10.1371/journal.ppat.1002402</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5C0982E9-7516-439A-8303-B56E7BA3010F</gtr:id><gtr:title>From Scientific Curiosity to Public Enemy Number One in Six Short Months.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>585d453cbb9af9.08705243</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>905B4D33-8D81-41D2-838E-4AF8A1C6E5CD</gtr:id><gtr:title>Follicular dendritic cell-specific prion protein (PrP) expression alone is sufficient to sustain prion infection in the spleen.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf9ca88eb9302095b0d8a372783d6bc3"><gtr:id>cf9ca88eb9302095b0d8a372783d6bc3</gtr:id><gtr:otherNames>McCulloch L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5432c405479943.07208668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAB398D9-1821-44C5-9093-4C7900726F79</gtr:id><gtr:title>Determining the role of follicular dendritic cells in scrapie pathogenesis</gtr:title><gtr:parentPublicationTitle>Prion 2009</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4cc7c28430e7151cd7bfae4d136dce5"><gtr:id>a4cc7c28430e7151cd7bfae4d136dce5</gtr:id><gtr:otherNames>Mucculloch, L.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>5432c56d4b6ae1.41967861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>226525D4-C4ED-4FCA-8FA3-4D510EE04165</gtr:id><gtr:title>Ablation of the cellular prion protein, PrPC, specifically on follicular dendritic cells has no effect on their maturation or function.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf9ca88eb9302095b0d8a372783d6bc3"><gtr:id>cf9ca88eb9302095b0d8a372783d6bc3</gtr:id><gtr:otherNames>McCulloch L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>5432c48c2168b0.63673494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E50730E-58C0-4282-8FFE-1DDACF7F6D18</gtr:id><gtr:title>Expression of mesenchyme-specific gene signatures by follicular dendritic cells: insights from the meta-analysis of microarray data from multiple mouse cell populations.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>5432c36c9b46a7.62108621</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB41D82F-9F1D-4EE8-BB0F-ED4A5F72BCED</gtr:id><gtr:title>Immunology of Prion Protein and Prions.</gtr:title><gtr:parentPublicationTitle>Progress in molecular biology and translational science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1877-1173</gtr:issn><gtr:outcomeId>5a85a3c46df934.26236870</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>958E1744-52E2-4678-91C6-3045665AB2E7</gtr:id><gtr:title>The effects of host age on follicular dendritic cell status dramatically impair scrapie agent neuroinvasion in aged mice.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/700fbb235965330040dfaa9897517a46"><gtr:id>700fbb235965330040dfaa9897517a46</gtr:id><gtr:otherNames>Brown KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>545a20134a8346.88907013</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C751A5CD-C3E1-45C2-9D40-CEF36F4ACCF9</gtr:id><gtr:title>Prion pathogenesis and secondary lymphoid organs (SLO): tracking the SLO spread of prions to the brain.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn><gtr:outcomeId>5432b3122a3cb0.30902370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D0A241A-CADD-4D62-9892-FC09027BCE22</gtr:id><gtr:title>Prospects for safe and effective vaccines against prion diseases.</gtr:title><gtr:parentPublicationTitle>Expert review of vaccines</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1476-0584</gtr:issn><gtr:outcomeId>545a1d541561c1.00042851</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A801995B-546F-45F2-BAA5-8A7227483733</gtr:id><gtr:title>Scrapie affects the maturation cycle and immune complex trapping by follicular dendritic cells in mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4335586719899bb90725ae0077acc26"><gtr:id>a4335586719899bb90725ae0077acc26</gtr:id><gtr:otherNames>McGovern G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5432c4b48e4ce1.02394329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD356AE8-EFC5-40F0-A5D2-6650B7F96F82</gtr:id><gtr:title>The role of follicular dendritic cells in scrapie pathogenesis</gtr:title><gtr:parentPublicationTitle>Joint Funders TSE Workshop</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58b50b85a5c5aa4a8934730e2b33cb29"><gtr:id>58b50b85a5c5aa4a8934730e2b33cb29</gtr:id><gtr:otherNames>McCulloch, L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>5432c5e7e2a7c8.24286879</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83AFC55E-C5AC-4D3F-BD14-D01FD2827C84</gtr:id><gtr:title>B cell-specific S1PR1 deficiency blocks prion dissemination between secondary lymphoid organs.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8bf108f93a0fafc59f36df35e5c04fb2"><gtr:id>8bf108f93a0fafc59f36df35e5c04fb2</gtr:id><gtr:otherNames>Mok SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>545a1f5bb73888.97559555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D1ACA2C-B80E-42EE-B6A1-5858F05AC664</gtr:id><gtr:title>Human prion diseases and the risk of their transmission during anatomical dissection.</gtr:title><gtr:parentPublicationTitle>Clinical anatomy (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e48b28ee4ab00aac6a546646ce68a2b"><gtr:id>4e48b28ee4ab00aac6a546646ce68a2b</gtr:id><gtr:otherNames>Bradford BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0897-3806</gtr:issn><gtr:outcomeId>5432b1b2da2698.55381044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18253BBC-1B1A-4DDC-97DB-DC5D8F12FBB0</gtr:id><gtr:title>MicroRNA-100-5p indirectly modulates the expression of Il6, Ptgs1/2 and Tlr4 mRNA in the mouse follicular dendritic cell-like cell line, FL-Y.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/432fa25d6fd8502375d2d09b60c08e83"><gtr:id>432fa25d6fd8502375d2d09b60c08e83</gtr:id><gtr:otherNames>Aungier SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>545a1dc6062fa8.16237171</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E775603-7977-4A71-BC0E-EA0B5BB38199</gtr:id><gtr:title>Investigating the role of follicular dendritic cells (FDCs) in scrapie pathogenesis</gtr:title><gtr:parentPublicationTitle>14th International Congress of Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c2bf5df51144d8a9301e67d5a7f4c0c"><gtr:id>8c2bf5df51144d8a9301e67d5a7f4c0c</gtr:id><gtr:otherNames>McCulloch, L.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>5432c63cd037b0.91599206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10F28636-CCCC-4510-A598-10B3DF6CBA22</gtr:id><gtr:title>Scrapie alters immune complex trapping and the maturation cycle of follicular dendritic cells</gtr:title><gtr:parentPublicationTitle>Prion 2009</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c7ae9e53dc7d88353438ca0c78449d1"><gtr:id>5c7ae9e53dc7d88353438ca0c78449d1</gtr:id><gtr:otherNames>McGovern, G.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>5432c702650fb8.21905668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D1C9944-7852-424E-915F-13DD9975A756</gtr:id><gtr:title>Determining the influence of the host immune system on TSE pathogenesis</gtr:title><gtr:parentPublicationTitle>EBRC Launch</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b32c6588e86101875805ed943e120df"><gtr:id>7b32c6588e86101875805ed943e120df</gtr:id><gtr:otherNames>MAbbott, N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>5432b9d34f9a59.02260776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8273146A-2C72-446B-A32C-61899B306AAE</gtr:id><gtr:title>The effects of host age on the transport of complement-bound complexes to the spleen and the pathogenesis of intravenous scrapie infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/700fbb235965330040dfaa9897517a46"><gtr:id>700fbb235965330040dfaa9897517a46</gtr:id><gtr:otherNames>Brown KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5432c3472c9cf1.43468237</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/D00831X/3</gtr:identifier></gtr:identifiers><gtr:projectHierarchy><gtr:parents><gtr:parent><gtr:id>7F619C86-7BCB-43BE-9302-57A9067E9EEB</gtr:id><gtr:grantRef>BB/D00831X/1</gtr:grantRef><gtr:amount>272166.4</gtr:amount><gtr:start>2006-09-01</gtr:start><gtr:end>2007-03-31</gtr:end><gtr:children><gtr:child rel="Transfer"><gtr:id>38643660-0774-4FE2-B39A-8701ADBAEA95</gtr:id><gtr:grantRef>BB/D00831X/2</gtr:grantRef><gtr:amount>232508.5</gtr:amount><gtr:start>2007-04-01</gtr:start><gtr:end>2008-04-30</gtr:end><gtr:children><gtr:child rel="Transfer"><gtr:id>A20B2CD3-EF9C-4046-ACF8-2D08CDE8ACE4</gtr:id><gtr:grantRef>BB/D00831X/3</gtr:grantRef><gtr:amount>162385.63</gtr:amount><gtr:start>2008-05-01</gtr:start><gtr:end>2010-02-28</gtr:end><gtr:children/></gtr:child></gtr:children></gtr:child></gtr:children></gtr:parent></gtr:parents></gtr:projectHierarchy><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>